You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VKTX Award Disclosure
Kelly-gemmell Dorothy Elizabeth · SEC Form 4 · Filed Aug 7, 2026
Award
Calculated transaction value
$0
Kelly-gemmell Dorothy Elizabeth Director
VKTX
Viking Therapeutics
VKTX
Transaction date
Aug 1, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 6 days later
VKTX daily price context
Close on/before transaction
$31.74
Jul 31, 2026
First close after public filing
$34.44
Aug 10, 2026
30-day return after filing
-2.21%
Through Sep 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.00001 per share
- Quantity / price
- 6,333 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002144542-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Viking Therapeutics, Inc. VKTX Current | Award | Aug 1, 2026 | $0 |
| Viking Therapeutics, Inc. VKTX | Award | Aug 1, 2026 | $0 |